Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pharma Majors to Gain from India
Yahoo/Zacks.com
Tuesday, August 18, 2009 - 6:11pm
tags:
India, GSK, Pfizer, Merck, Mylan, Dr Reddy's, Sanofi
Feeling Fine With Big Pharma
Forbes
Tuesday, August 18, 2009 - 6:07pm
tags:
Big Pharma
More Bad News for Vytorin and Zetia?
WSJ Online
Tuesday, August 18, 2009 - 3:58pm
tags:
Merck, Schering Plough, Vytorin, Zetia, Niaspan, Abbott Laboratories
Geron: Huge Potential in Oncology, Regenerative Med Pipeline
Seeking Alpha
Tuesday, August 18, 2009 - 3:56pm
tags:
Geron, oncology, pipelines
Not Buying Cel Sci's Swine Flu PR
Seeking Alpha
Tuesday, August 18, 2009 - 3:35pm
tags:
swine flu, Cel-Sci, H1N1
Durect licenses ADHD drug to Orient Pharma
Yahoo/AP
Tuesday, August 18, 2009 - 3:33pm
tags:
Durect Corporation, ADHD, liscensing, Orient Pharma
Amgen Banks on New Drug: Best in Class
TheStreet.com
Tuesday, August 18, 2009 - 3:29pm
tags:
Amgen, osteoporosis, denosumab
Data backs Avastin as second-line treatment
Fierce Pharma
Tuesday, August 18, 2009 - 11:22am
tags:
Roche, Avastin, breast cancer, Genentech
Drug stocks diverge; Novavax jumps on flu update
Marketwatch
Tuesday, August 18, 2009 - 11:16am
tags:
drug stocks, Novavax
Redefining Pfizer and the way it researches drugs
Fortune
Tuesday, August 18, 2009 - 11:11am
tags:
Jeff Kindler, Pharma CEOs, Pfizer
Skystar Bio-Pharmaceutical: Significantly Undervalued
Seeking Alpha
Tuesday, August 18, 2009 - 11:10am
tags:
Skystar Bio-Pharmaceutical, earnings
Big French Pharma Moves to Distance Itself from U.S. Healthcare Protests
Seeking Alpha
Tuesday, August 18, 2009 - 9:36am
tags:
France, Bristol-Myers Squibb, Sanofi
NOVAVAX Virus-Like Particle Vaccine Protects Against 2009 Pandemic H1N1 Influenza Virus
Yahoo
Tuesday, August 18, 2009 - 9:33am
tags:
Novavax, vaccines, swine flu, H1N1
Abbott Announces Partnership with Velcera to Bring New Pain Medication for Dogs to Market
Yahoo
Tuesday, August 18, 2009 - 9:28am
tags:
Abbott Laboratories, partnerships, Velcera, veterinary medicine
Genmab slumps as Glaxo-partnered drug hits setback
Reuters
Tuesday, August 18, 2009 - 8:44am
tags:
GSK, Genmab, Arzerra, lymphoma
King Pharma Financial Gauge Analysis for June 2009 Quarter
Seeking Alpha
Tuesday, August 18, 2009 - 8:24am
tags:
King
Cramer Likes Orexigen: Should You?
Seeking Alpha
Tuesday, August 18, 2009 - 8:04am
tags:
Orexigen, Contrave, obesity
Court invalidates 1 of Lilly's Gemzar patents
Yahoo/AP
Tuesday, August 18, 2009 - 8:03am
tags:
Eli Lilly, Gemzar, patents, generics, cancer, Sun Pharma
Avigen Still a Good Value
Seeking Alpha
Tuesday, August 18, 2009 - 6:26am
tags:
Avigen, Genzyme, MediciNova
United Therapeutics' Growth Driven By Approval Of Two New Treatments
Yahoo/Investors Business Daily
Tuesday, August 18, 2009 - 6:24am
tags:
United Therapeutics, Pfizer, Eli Lilly, Gilead Sciences, Tyvaso, Adcirca

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.